Ling Xu

14PUBLICATIONS

42CO-AUTHORS

Haematological tumoursMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersTumour immunology

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (14)

Sort by Publication Date:

|Jun 22, 2026

CD69 blockade restores the bone marrow niche and delays leukemogenesis in a mouse model of <i>Nras</i> <sup>G12D</sup>-driven chronic myelomonocytic leukemia.

|Feb 06, 2024

BCL11B promotes T-cell acute lymphoblastic leukaemia cell survival via the XRCC5/C11ORF21 axis.

Xibao Yu, Yuchen Li, Pengyue Yang

|Jan 18, 2024

Inhibition of NRF2 enhances the acute myeloid leukemia cell death induced by venetoclax via the ferroptosis pathway.

Xibao Yu, Yan Wang, Jiaxiong Tan

|Jan 15, 2024

CD69 is a Promising Immunotherapy and Prognosis Prediction Target in Cancer.

Yuchen Li, Yinfeng Gu, Pengyue Yang

|Sep 29, 2023

Correction: Targeting LAG-3, TIM-3, and TIGIT for cancer immunotherapy.

Letong Cai, Yuchen Li, Jiaxiong Tan

|Sep 05, 2023

Targeting LAG-3, TIM-3, and TIGIT for cancer immunotherapy.

Letong Cai, Yuchen Li, Jiaxiong Tan

Pageof 3

Frequent Collaborators

13 joint publications

Yangqiu Li

Zhenyi Jin

Shaohua Chen

Yikai Zhang

Xibao Yu

Xianfeng Zha

Xiangbo Zeng

Cunte Chen

Yuchen Li

Siyang Maggie Liu

Frequent Collaborators

13 joint publications

Yangqiu Li

4 joint publications

Zhenyi Jin

4 joint publications

Shaohua Chen

4 joint publications

Yikai Zhang